Plus Therapeutics (PSTV) Change in Receivables (2010 - 2020)
Plus Therapeutics (PSTV) reported Change in Receivables of -$951000.0 for Q3 2020, down 119.72% year-over-year from $4.8 million in Q4 2019, and down 3422.22% quarter-over-quarter from -$27000.0 in Q2 2020.
Plus Therapeutics (PSTV) Change in Receivables (2010 - 2020) Analysis & Trends
Plus Therapeutics (PSTV) has 11 years of Change in Receivables data on file, last reported at -$951000.0 in Q3 2020.
- Change in Receivables for Q3 2020 came in at -$951000.0, down 119.72% year-over-year; the trailing twelve-month figure through Jun 2021 was -$951000.0 (down 199.37% YoY), and the FY2020 annual result was -$1.2 million, down 197.17% from the prior year.
- Change in Receivables retreated to -$951000.0 in Q3 2020 per PSTV's latest filing, from -$27000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $4.8 million in Q3 2019 and troughed at -$3.6 million in Q4 2019.
- A 5-year average of -$39105.3 and a median of -$138000.0 in 2017 frame the typical range for Change in Receivables.
- On a YoY basis, Change in Receivables climbed as much as 11383.33% in 2019 and fell as far as 2451.05% in 2019.
- A 5-year view of Change in Receivables shows it stood at $270000.0 in 2016, then plunged by 151.11% to -$138000.0 in 2017, then dropped by 3.62% to -$143000.0 in 2018, then plunged by 2451.05% to -$3.6 million in 2019, then soared by 73.93% to -$951000.0 in 2020.
- Business Quant data shows PSTV's Change in Receivables at -$951000.0 in Q3 2020, -$27000.0 in Q2 2020, and -$191000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -4.08 Mn |
| 10 | Plus Therapeutics | 34.26 Mn | 19.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -951,000.00 |
| Sep 30, 2020 | -951,000.00 |
| Jun 30, 2020 | -27,000.00 |
| Jun 30, 2020 | -27,000.00 |
| Mar 31, 2020 | -191,000.00 |
| Mar 31, 2020 | -191,000.00 |
| Dec 31, 2019 | -3.65 Mn |
| Dec 31, 2019 | -3.65 Mn |
| Sep 30, 2019 | 4.82 Mn |
| Sep 30, 2019 | 4.82 Mn |
| Jun 30, 2019 | -184,000.00 |
| Jun 30, 2019 | -184,000.00 |
| Mar 31, 2019 | 212,000.00 |
| Mar 31, 2019 | 212,000.00 |
| Dec 31, 2018 | -143,000.00 |
| Dec 31, 2018 | -143,000.00 |
| Sep 30, 2018 | 42,000.00 |
| Sep 30, 2018 | 42,000.00 |
| Jun 30, 2018 | -473,000.00 |
| Jun 30, 2018 | -473,000.00 |